Concepedia

James H. Lillibridge

JH

Statistics

Publications

5

Citations

455

H-Index

5

Active since

1993

Affiliations

University of Washington(Current)

Agouron Institute

James H. Lillibridge is an author at University of Washington specializing in pharmacotherapy, drug discovery, and pharmacokinetics.

Top concepts

Publications per year

1993–2001

5

Publications

5

Pharmacokinetic Interactions between Nelfinavir and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Atorvastatin and Simvastatin

Poe‐Hirr Hsyu, Melissa D. Schultz-Smith, James H. Lillibridge et al. · Antimicrobial Agents and Chemotherapy · 2001 · 144 citations · Full text

Single-dose disulfiram inhibition of chlorzoxazone metabolism: A clinical probe for P450 2E1

Evan D. Kharasch, Kenneth E. Thummel, J. G. Mhyre et al. · Clinical Pharmacology & Therapeutics · 1993 · 126 citations

, , +17

Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate.

James H. Lillibridge, Bai Hong Liang, Bradley M. Kerr et al. · PubMed · 1998 · 107 citations

, , +14

PROTEIN-REACTIVE METABOLITES OF CARBAMAZEPINE IN MOUSE LIVER MICROSOMES

James H. Lillibridge, Benny Amore, John T. Slattery et al. · Drug Metabolism and Disposition · 1996 · 54 citations

Effects of caffeine and theophylline on acetaminophen pharmacokinetics: P450 inhibition and activation.

Caroline A. Lee, James H. Lillibridge, Sidney D. Nelson et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 24 citations

1–5 of 5